|
|||||
|
|
| Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function | |
| 作者姓名： | Long SA,Rieck M,Sanda S,Bollyky JB,Samuels PL,Goland R,Ahmann A,Rabinovitch A,Aggarwal S,Phippard D,Turka LA,Ehlers MR,Bianchine PJ,Boyle KD,Adah SA,Bluestone JA,Buckner JH,Greenbaum CJ for Diabetes TrialNet and the Immune Tolerance Network |
| 摘 要： | |
| 收稿时间： | 2012-01-13 |
| 本文献已被 PubMed 等数据库收录！ | |